Octagon Capital Advisors LP

Holdings History for Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Symbol: TSHA on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned: 9,067,500 shares
Security Ownership %: 3.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Octagon Capital Advisors LP ownership in Taysha Gene Therapies, Inc. Common Stock, par value $0.00001 per share (TSHA)

14 Nov 2025 - Octagon Capital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,067,500 shares of Taysha Gene Therapies, Inc. Common Stock, par value $0.00001 per share (TSHA). This represents 3.3% ownership of the company. In their previous filing dated 05 Feb 2025, Octagon Capital Advisors LP had reported owning 10,450,000 shares, indicating a decrease of +13%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Octagon Capital Advisors LP	3.3%	-36%	$29,650,725	9,067,500	-1,382,500	-13%	$3.27	13G/A	30 Sep 2025	14 Nov 2025, 16:46
Octagon Capital Advisors LP	5.1%		$19,019,000	10,450,000			$1.82	13G	31 Dec 2024	05 Feb 2025, 18:05

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	6.1%	-0.14%	$48,729,511	8,859,911	-207,589	-2.3%	$5.50	Q4 2025
30 Sep 2025	4.6%	-1.8%	$29,650,725	9,067,500	-3,525,000	-28%	$3.27	Q3 2025
30 Jun 2025	6.4%	+0.96%	$29,088,675	12,592,500	+1,892,500	+18%	$2.31	Q2 2025
31 Mar 2025	3.2%	+0.08%	$14,873,000	10,700,000	+250,000		$1.39	Q1 2025
31 Dec 2024	3.1%	+1.7%	$18,078,500	10,450,000	+5,877,778	+129%	$1.73	Q4 2024
30 Sep 2024	1.5%	0%	$9,190,166	4,572,222	0		$2.01	Q3 2024
30 Jun 2024	1.7%	+0.42%	$10,241,777	4,572,222	+1,542,222	+51%	$2.24	Q2 2024
31 Mar 2024	1.1%	+1.1%	$8,696,100	3,030,000	+3,030,000	NEW	$2.87	Q1 2024
31 Dec 2023		-1.5%	$0	0	-2,777,778	-100%	$4.70	Q4 2023
30 Sep 2023	1.5%	+1.5%	$8,777,778	2,777,778	+2,777,778	NEW	$3.16	Q3 2023
30 Sep 2021		-1.4%	$0	0	-320,440	-100%	$4.70	Q3 2021
30 Jun 2021	1.4%	0%	$6,793,000	320,440	0		$21.20	Q2 2021
31 Mar 2021	2.5%	0%	$6,505,000	320,440	0		$20.30	Q1 2021
31 Dec 2020	2.9%	0%	$8,504,000	320,440	0		$26.54	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.